CMS proposes narrowly covering controversial Alzheimer’s drug Aduhelm for patients in clinical trials

The Biden administration is proposing to have Medicare cover the controversial Alzheimer’s disease medication Aduhelm, but only for patients in relevant clinical trials.

The Centers for Medicare & Medicaid Services (CMS) released Tuesday a proposed national coverage determination for Medicare…